Thursday, 28 October 2021

Tag Archives: drugmaker

Roche ‘disappointed’ with trial results for colitis drug

ZURICH: Roche Holding’s experimental drug etrolizumab did not fare well in late-stage clinical trials in treating people with moderate to severe ulcerative colitis, the Swiss drugmaker said. “Mixed results were seen in studies evaluating etrolizumab as an induction therapy, and both studies evaluating etrolizumab as a maintenance therapy failed to ...

Read More »

GSK long-acting HIV injection succeeds in study

GlaxoSmithKline’s prospective two-monthly two-drug injection to treat HIV was as effective as a monthly dose of the same regimen in maintaining viral suppression at 48 weeks in a late-stage study, the British drugmaker said. The long-acting needle-based combination of its drug cabotegravir and Janssen’s treatment rilpivirine met its main goal ...

Read More »